Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

CAPS Rating: 3 out of 5

A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.

Recs

0
Player Avatar juanocb12 (64.80) Submitted: 9/8/2008 12:05:40 PM : Outperform Start Price: $37.01 ONXX Score: +17.66

Possible buyout by Bayer

Featured Broker Partners


Advertisement